Article
Clinical use of adipose-derived stem cells: European legislative issues
10 Nov 2017
Abstract excerpt
OBJECTIVE: With this study we analyse the current European legislation in order to provide guidance for regenerative medicine professionals on correct Adipose-derived Stem Cells (ASCs) isolation and use protocols for clinical applications. MATERIALS AND METHODS: The European Medicines Agency (EMA) considers that ASCs does not fall within the definition of an advanced therapy medicinal product if the cells have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
